Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 4, 2011

Domainex wins grant to develop cancer drug

The UK's Technology Strategy Board has awarded Domainex a £250,000 grant to develop of a new drug to treat several common cancers.

The UK’s Technology Strategy Board has awarded Domainex a £250,000 grant to develop of a new drug to treat several common cancers.

The drug will act by inhibiting two protein kinases, TBK1 and IKKe, which will suppress certain cancer cell lines from growing.

The aim of the project is to identify a drug candidate that is effective in disease models and would be orally well-absorbed by humans.

Domainex research director Trevor Perrior said that the novel mode of action will allow the treatment of patients with drug-resistant, triple-negative tumours.

The marketing of the new drug will be done in partnership with a large pharmaceutical company that has the ability to conduct drug trials, Domainex said.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU